oliver sartor, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
Published 4 years ago • 71 plays • Length 1:01
Download video MP4
Download video MP3
Similar videos
-
0:51
rana mckay, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
-
0:42
oliver sartor, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
1:32
bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
-
0:47
tom beer, md on the data presented at asco gu20 investigating atezolizumab and cabozantinib in mcrpc
-
0:37
tanya dorff, md, elaborates on data investigating atezolizumab and cabozantinib in prostate cancer
-
0:53
oliver sartor, md, on future use of liquid biopsy into the treatment of prostate cancer
-
1:00
oliver sartor, md, regarding recent outcomes investigating 225ac-psma-617 in patients with apc
-
1:28
oliver sartor, md, shares data of cellular immunotherapy within the african american population
-
4:02
precision medicine in prostate cancer
-
27:50
psma targeted radionuclide therapy - prof. uwe haberkorn
-
53:09
the oncoalert tumor boards prostate cancer june 20, 2022
-
0:57
oliver sartor, md, on the recent outcomes investigating lu-177–psma in patients with apc
-
1:13
dr. agarwal on data with cabozantinib/atezolizumab in mcrpc
-
1:10
daniel petrylak, md, on investigating atezolizumab and cabozantinib relating to prostate cancer
-
3:06
titan trial
-
5:03
atezolizumab with ebrt for bladder preservation in mibc
-
12:41
cabozantinib in combination with atezolizumab in patients with mcrpc
-
8:38
cabozantinib plus atezolizumab for patients with metastatic castration-resistant prostate cancer
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
1:30
dr. sartor on the vision trial in mcrpc
-
0:56
dr. shinohara on pairing sbrt with immunotherapy in prostate cancer
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
Clip.africa.com - Privacy-policy